Total Payments
$16,950
2024 Payments
$2,769
Companies
51
Transactions
831
Medicare Patients
8,849
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$15,627 (92.2%)
Travel$1,067 (6.3%)
Education$255.49 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,627 | 818 | 92.2% |
| Travel and Lodging | $1,067 | 4 | 6.3% |
| Education | $255.49 | 9 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,614 | 169 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,865 | 94 | $0 (2024) |
| Inspire Medical Systems, Inc. | $1,098 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,019 | 64 | $0 (2024) |
| Mylan Specialty L.P. | $999.26 | 53 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $961.02 | 23 | $0 (2024) |
| Grifols USA, LLC | $795.26 | 49 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $681.07 | 53 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $618.10 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $544.19 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,769 | 108 | GlaxoSmithKline, LLC. ($430.55) |
| 2023 | $3,191 | 111 | Inspire Medical Systems, Inc. ($1,082) |
| 2022 | $2,168 | 111 | GlaxoSmithKline, LLC. ($303.47) |
| 2021 | $1,429 | 89 | GlaxoSmithKline, LLC. ($205.89) |
| 2020 | $1,217 | 75 | GlaxoSmithKline, LLC. ($239.00) |
| 2019 | $2,038 | 120 | GlaxoSmithKline, LLC. ($342.67) |
| 2018 | $2,553 | 124 | Jazz Pharmaceuticals Inc. ($602.25) |
| 2017 | $1,585 | 93 | GlaxoSmithKline, LLC. ($325.77) |
All Payment Transactions
831 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.56 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: HFCWO | ||||||
| 12/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: Cardiology | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $26.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/03/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: ANTIBIOTIC | ||||||
| 11/20/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $176.25 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.54 | General |
| Category: HFCWO | ||||||
| 11/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/11/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 2,155 | 2,607 | $988,956 | $270,032 |
| 2022 | 19 | 2,259 | 2,744 | $991,419 | $270,576 |
| 2021 | 18 | 2,487 | 2,957 | $1.2M | $335,245 |
| 2020 | 18 | 1,948 | 2,420 | $1.0M | $282,035 |
Total Patients
8,849
Total Services
10,728
Medicare Billing
$1.2M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 123 | 136 | $297,568 | $64,327 | 21.6% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 136 | 136 | $274,448 | $59,960 | 21.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 296 | 461 | $80,675 | $41,794 | 51.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 380 | 493 | $69,020 | $31,188 | 45.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 23 | 71 | $43,310 | $11,607 | 26.8% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 245 | 255 | $37,485 | $10,088 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 81 | 81 | $17,739 | $9,022 | 50.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 246 | 256 | $29,440 | $8,066 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 98 | 98 | $15,680 | $7,951 | 50.7% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 81 | 84 | $33,600 | $5,510 | 16.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 88 | $10,824 | $5,328 | 49.2% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 72 | 72 | $32,250 | $5,248 | 16.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 188 | 214 | $20,544 | $4,152 | 20.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 117 | 121 | $19,360 | $3,190 | 16.5% |
| 94660 | Therapy procedure using a positive pressure ventilator | Office | 2023 | 29 | 30 | $3,900 | $1,312 | 33.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $3,113 | $1,287 | 41.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 128 | 136 | $297,568 | $64,079 | 21.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 126 | 127 | $262,128 | $56,972 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 446 | 609 | $85,260 | $36,190 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 229 | 350 | $61,250 | $30,918 | 50.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 81 | $49,410 | $13,622 | 27.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 283 | 299 | $43,953 | $12,233 | 27.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 106 | 106 | $23,214 | $12,114 | 52.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 278 | 295 | $33,925 | $9,248 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 90 | 90 | $14,400 | $6,530 | 45.3% |
About Dr. Sever Surdulescu, MD
Dr. Sever Surdulescu, MD is a Sleep Medicine healthcare provider based in Mooresville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710998802.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sever Surdulescu, MD has received a total of $16,950 in payments from pharmaceutical and medical device companies, with $2,769 received in 2024. These payments were reported across 831 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($15,627).
As a Medicare-enrolled provider, Surdulescu has provided services to 8,849 Medicare beneficiaries, totaling 10,728 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Sleep Medicine
- Other Specialties Pulmonary Disease
- Location Mooresville, NC
- Active Since 08/11/2006
- Last Updated 10/12/2020
- Taxonomy Code 207RS0012X
- Entity Type Individual
- NPI Number 1710998802
Products in Payments
- INSPIRE (Device) $1,098
- NUCALA (Biological) $1,097
- DUPIXENT (Biological) $990.57
- TRELEGY ELLIPTA (Drug) $708.82
- Prolastin-C Liquid (Biological) $686.03
- OFEV (Drug) $606.91
- Yupelri (Drug) $597.00
- GLASSIA (Biological) $484.65
- Arikayce (Drug) $429.13
- ACTHAR (Biological) $426.27
- SYMBICORT (Drug) $368.36
- LONHALA MAGNAIR (Drug) $338.60
- YUPELRI (Drug) $334.66
- NUZYRA (Drug) $291.24
- WAKIX (Drug) $282.15
- AIRSUPRA (Drug) $281.66
- ANORO (Drug) $273.56
- BREZTRI (Drug) $268.78
- STIOLTO RESPIMAT (Drug) $259.67
- Esbriet (Biological) $250.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.